Stock 4549 EIKEN CHEMICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Eiken Chemical Co., Ltd. Share Price

Equities

4549

JP3160700005

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 07:00:00 26/04/2024 BST 		5-day change 1st Jan Change
2,007 JPY -0.89% Intraday chart for Eiken Chemical Co., Ltd. +3.72% +17.44%
03-21 Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024. CI
03-19 Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million. CI

Financials

Sales 2024 * 40.32B 255M 20.38B Sales 2025 * 41.82B 264M 21.14B Capitalization 69.44B 438M 35.1B
Net income 2024 * 3.47B 21.92M 1.76B Net income 2025 * 3.54B 22.32M 1.79B EV / Sales 2024 * 1.38 x
Net cash position 2024 * 13.74B 86.72M 6.94B Net cash position 2025 * 14.48B 91.44M 7.32B EV / Sales 2025 * 1.31 x
P/E ratio 2024 *
21.4 x
P/E ratio 2025 *
20.6 x
Employees 754
Yield 2024 *
2.49%
Yield 2025 *
2.49%
Free-Float 75.39%
More Fundamentals * Assessed data

Chart Eiken Chemical Co., Ltd.

Dynamic Chart

Latest news about Eiken Chemical Co., Ltd.

Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024. CI
Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million. CI
Eiken Chemical Co., Ltd. announces an Equity Buyback for 2,700,000 shares, representing 7.28% for ¥5,400 million. CI
Eiken Chemical Co., Ltd. authorizes a Buyback Plan. CI
Lucira Health, Inc. Provides Notice of Termination of the Patent License Agreement by and Between the Company and Eiken Chemical Co., Ltd CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2020 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019 CI
Medicinal Genomics Corp. Partners with Eiken Chemical Co., Ltd. for Cannabis Testing to Drive Higher Yield CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018 CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018 CI
Eiken Chemical Co., Ltd. Revised Consolidated and Non Consolidated Earnings Guidance for the First Six Months of Fiscal Year Ending September 30, 2017 CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the First Half Year of Fiscal 2018 and Full Year Ending March 2018 CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Full Year of 2018; Declares Consolidated Dividend for the Year Ended March 31, 2017, Payable on June 5, 2017; Provides Dividend Guidance for the Fiscal First Half of 2018 and Full Year of 2018 CI
Eiken Chemical Co., Ltd. Revises Consolidated and Non Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2017 CI
More news

Press releases Eiken Chemical Co., Ltd.

Eiken Chemical : Consolidated Financial Results for the Six Months Ended September 30, 2023 PU
Eiken Chemical : Business Results for the First Three Months of fiscal year ending March 31, 2024 PU
Eiken Chemical : Bridge Report for the Fiscal Year Ended March 31, 2023 PU
Eiken Chemical : Business Results for the Fiscal Year Ended March 31, 2023 PU
Eiken Chemical : Business Results for the First Nine Months of fiscal year ending March 31, 2023 PU
More press releases

Quotes and Performance

1 day-0.89%
1 week+3.72%
Current month+0.35%
1 month+1.83%
3 months+13.52%
6 months+41.44%
Current year+17.44%
More quotes

Highs and lows

1 week
1 947.00
Extreme 1947
2 037.00
1 month
1 908.00
Extreme 1908
2 049.00
Current year
1 678.00
Extreme 1678
2 055.00
1 year
1 334.00
Extreme 1334
2 055.00
3 years
1 334.00
Extreme 1334
2 340.00
5 years
1 334.00
Extreme 1334
2 600.00
10 years
778.00
Extreme 778
2 862.00
More quotes

Managers and Directors - Eiken Chemical Co., Ltd.

Managers TitleAgeSince
Tsugunori Notomi PSD
 President 65 31/03/81
Hidetoshi Kanda CTO
 Chief Tech/Sci/R&D Officer 63 28/02/85
Hajime Watari ADM
 Chief Administrative Officer 63 28/02/85
Members of the board TitleAgeSince
Akira Fujiyoshi BRD
 Director/Board Member 70 22/06/20
Morifumi Wada BRD
 Director/Board Member 69 28/02/78
Tsugunori Notomi PSD
 President 65 31/03/81
More insiders

ETFs positioned on Eiken Chemical Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY ETF Nomura NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY
0.15% 15 M€ +7.34%
DAIWA ETF MSCI JAPAN EMPOWERING WOMEN INDEX ETF - JPY ETF Daiwa ETF MSCI Japan Empowering Women Index ETF - JPY
0.02% 4 M€ +13.95%
NZAM ETF TOPIX EX-FINANCIALS - JPY ETF NZAM ETF TOPIX Ex-Financials - JPY
0.01% 18 M€ +16.15% -
MAXIS TOPIX ETF - JPY ETF MAXIS TOPIX ETF - JPY
0.01% 20,721 M€ +13.52% -
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY ETF Nomura TOPIX Exchange Traded Fund ETF - JPY
0.01% 144,586 M€ +14.49%
More ETFs positioned on Eiken Chemical Co., Ltd.

Quotes

Date Price Change Volume
26/04/24 2,007 -0.89% 94,400
25/04/24 2,025 +1.00% 147,600
24/04/24 2,005 -0.05% 45,500
23/04/24 2,006 +2.40% 116,900
22/04/24 1,959 +1.24% 53,200

Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am

More quotes

Company Profile

EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Sector
Medical Equipment, Supplies & Distribution
Calendar
08/05/2024 - Q4 2023 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Eiken Chemical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2,007 JPY
Average target price
1,750 JPY
Spread / Average Target
-12.81%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
EIKEN CHEMICAL CO., LTD. Stock Eiken Chemical Co., Ltd.
+17.44% 441M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 4549 Stock